References
- Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 2006;6:589-601. https://doi.org/10.1016/S1473-3099(06)70580-1
- Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016;16:161-8. https://doi.org/10.1016/S1473-3099(15)00424-7
- Hasman H, Hammerum AM, Hansen F, Hendriksen RS, Olesen B, Agerso Y, et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill 2015;20(49).
- The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0, 2016. http://www.eucast.org/clinical_breakpoints (Last visited on Nov 2016).
- Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin. 2015;31:707-21. https://doi.org/10.1185/03007995.2015.1018989
-
Kang C, Cha MC, Kim SH, Ko KS, Wi YM, Chung DR, et al. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum
$\beta$ -lactamase-producing Escherichia coli over a 6-year period. J Korean Med Sci 2013;28:998-1004. https://doi.org/10.3346/jkms.2013.28.7.998
Cited by
- Identification of an extensively drug-resistant Escherichia coli clinical strain harboring mcr-1 and blaNDM-1 in Korea vol.73, pp.12, 2017, https://doi.org/10.1038/s41429-020-0350-1